Synchroneuron, Inc.

Eisai R&d Management Co., Ltd.

William D Kerns

Barry S Fogel

Kei-Lai Fong

David N Wong

Daniel P Rossignol

Edward Lin

San-Laung Chow

Melvyn Lynn

David Wong

Embodiments disclosed herein generally relate to methods of treating posttraumatic stress disorder (PTSD) using acamprosate formulations and/or acamprosate formulations in combination with at least one other medication, such as neuroleptic (antipsychotic) and/or antidepressant drugs.

Methods of treating posttraumatic stress disorder with acamprosate salts

Embodiments disclosed herein generally relate to acamprosate formulations, methods of use of the formulations, to methods of using the formulations optionally in combination with at least one other medication, and to combination products and compositions comprising acamprosate and at least one other medication, such as neuroleptic (antipsychotic) and/or antidepressant drugs.

Acamprosate formulations, methods of using the same, and combinations comprising the same

Embodiments disclosed herein generally relate to acamprosate formulations, methods of use of the formulations, to methods of using the formulations in combination with at least one other medication, and to combination products and compositions comprising the formulations and at least one other medication, such as neuroleptic (antipsychotic) and/or antidepressant drugs.

Growing community of inventors

Harvard, MA, United States of America

William D Kerns